Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 1/2 1

Status

Unknown 2Withdrawn 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Lymphoid 21Other hematologic neoplasm 16Plasma cell 4Genitourinary 4Myeloid 3Gastrointestinal 3Thoracic 1Other solid neoplasm 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Prostatic Neoplasms 5024Carcinoma, Renal Cell 1577Urinary Bladder Neoplasms 1279Kidney Neoplasms 724Breast Neoplasms 643Neoplasms 630Carcinoma, Transitional Cell 490Carcinoma, Non-Small-Cell Lung 469Neoplasm Metastasis 468Melanoma 422Ovarian Neoplasms 401Colorectal Neoplasms 373Lung Neoplasms 333Pancreatic Neoplasms 262Sarcoma 233Stomach Neoplasms 227Uterine Cervical Neoplasms 225Testicular Neoplasms 216Non-Muscle Invasive Bladder Neoplasms 215Head and Neck Neoplasms 192Squamous Cell Carcinoma of Head and Neck 189Colonic Neoplasms 167Carcinoma, Hepatocellular 167Esophageal Neoplasms 165Endometrial Neoplasms 165Wilms Tumor 159Recurrence 131Triple Negative Breast Neoplasms 130Small Cell Lung Carcinoma 127Neuroblastoma 127

Interventions

Standard of Care 2tocilizumab 1proxalutamide 1Practice Guidelines as Topic 1Immunoglobulin G 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × COVID-19 × Genitourinary × Clear all
NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

Applied Biology, Inc.

Phase NA Completed
268 enrolled 8 charts
Genitourinary

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

NCT05009186 2021-08-17

Changing of Prostate Specific Antigen Value in Patients With Covid-19

Saglik Bilimleri Universitesi

Phase NA Unknown
100 enrolled
Genitourinary

COVID-19, Prostatic Neoplasms

NCT04834089 2021-04-08

SOROCOV

Butantan Institute

Phase 1/2 Unknown
618 enrolled
Genitourinary

COVID-19, Cardiovascular Diseases, Diabetes Mellitus, Kidney Diseases, Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Emory University

Phase 3 Withdrawn
Genitourinary

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡